Robert Barrow
2023
In 2023, Robert Barrow earned a total compensation of $2.1M as Chief Executive Officer at Mind Medicine (MindMed), a 59% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $318,725 |
|---|---|
| Salary | $598,750 |
| Stock Awards | $1,212,000 |
| Other | $13,658 |
| Total | $2,143,133 |
Barrow received $1.2M in stock awards, accounting for 57% of the total pay in 2023.
Barrow also received $318.7K in non-equity incentive plan, $598.8K in salary and $13.7K in other compensation.
Rankings
In 2023, Robert Barrow's compensation ranked 468th out of 2,647 executives tracked by ExecPay. In other words, Barrow earned more than 82.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 468 out of 2,647 | 82nd |
Division Manufacturing | 270 out of 1,447 | 81st |
Major group Chemicals And Allied Products | 188 out of 817 | 77th |
Industry group Drugs | 185 out of 783 | 76th |
Industry Medicinal Chemicals and Botanical Products | 4 out of 17 | 77th |
Source: SEC filing on April 26, 2024.
Barrow's colleagues
We found two more compensation records of executives who worked with Robert Barrow at Mind Medicine (MindMed) in 2023.